Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
marco.salvetti@uniroma1.it
Marco Salvetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
marco.salvetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
FRONTIERS IN NEUROLOGY
2022
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION
2022
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease
BioRxiv
2022
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
FRONTIERS IN NEUROLOGY
2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis
MULTIPLE SCLEROSIS AND RELATED DISORDERS
2022
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies
JOURNAL OF NEUROLOGY
2022
Distal upper limb involvement in myasthenia-myositis association
NEUROLOGICAL SCIENCES
2022
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment
JOURNAL OF NEURAL TRANSMISSION
2022
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures
JOURNAL OF NEUROSURGICAL SCIENCES
2022
Signs and symptoms of COVID-19 in patients with multiple sclerosis
EUROPEAN JOURNAL OF NEUROLOGY
2022
CADASIL or MS? Consider “Red Flags” but Avoid a Misdiagnosis: Case Series of a Concomitant Diagnosis
ARCHIVES OF CLINICAL AND MEDICAL CASE REPORTS
2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
FRONTIERS IN NEUROLOGY
2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
MULTIPLE SCLEROSIS AND RELATED DISORDERS
2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register
MULTIPLE SCLEROSIS
2022
Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
FRONTIERS IN NEUROLOGY
2022
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease: A Pilot Study
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
CURRENT NEUROPHARMACOLOGY
2022
Machine Learning use for prognostic purposes in Multiple Sclerosis
LIFE
2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation
MULTIPLE SCLEROSIS
2021
Facing the urgency of therapies for progressive MS — a Progressive MS Alliance proposal
NATURE REVIEWS. NEUROLOGY
2021
« prima
< precedente
1
2
3
4
5
6
7
8
seguente ›
ultima »
Progetti di Ricerca
Looking for final effectors of regulome alterations in MS: LMP1-mediated dysregulation of AID in MS pathogenesis
Epstein-Barr virus genotypes in multiple sclerosis
Impact of genetic and non-genetic risk factors for MS on regulatory RNAs.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma